WILMINGTON, Del.–(BUSINESS WIRE)–AstraZeneca (NYSE: AZN) announced today the installation of a 7,300-panel solar energy project that produces energy equivalent to about 10 percent of the campus’ office building electricity use.
“We need to make things in America again, and emerging opportunities in green energy are critical to putting Americans back to work while protecting the environment”
The 1.7 megawatt system, which is the largest non-utility solar project in Delaware, will produce green electricity that is the equivalent of removing the greenhouse gas emissions of more than 300 cars from the road per year.
“Producing green electricity is a significant step toward reducing the impact we have on the environment globally,” said Rich Fante, President, AstraZeneca U.S. & CEO, North America. “AstraZeneca is committed to doing its part to create a cleaner, more energy-efficient Delaware.”
The project is expected to produce 2.1 million kilowatt hours of electricity per year, which is enough to power about 100 homes. It also will reduce carbon dioxide emissions by 1,200 metric tons per year.
“By choosing to use renewable and sustainable energy sources, AstraZeneca is investing in its energy future. It’s great they made that investment with Motech, putting a Delaware employer to work to help power the buildings where hundreds of Delawareans are working,” Governor Jack Markell said. “By moving to renewable and sustainable energy sources, AstraZeneca is investing in its future and the future of our state. This project makes economic and environmental sense.”
“We need to make things in America again, and emerging opportunities in green energy are critical to putting Americans back to work while protecting the environment,” U.S. Rep. John Carney of Delaware said. “Delaware is positioned to be a national leader in these efforts because of partnership and coordination among private businesses and government. AstraZeneca has set a strong example of how to incorporate clean, environmentally-friendly policies into their business practices, and I’m confident they will continue to pursue additional green energy options for many years to come.”
The project is the third and by far largest solar project on the Wilmington campus, with the first two installed in 2004 and 2008.
AstraZeneca is a global, innovation-driven biopharmaceutical business with a primary focus on the discovery, development and commercialization of prescription medicines for gastrointestinal, cardiovascular, neuroscience, respiratory and inflammation, oncology and infectious disease. AstraZeneca operates in over 100 countries and its innovative medicines are used by millions of patients worldwide.
For more information about AstraZeneca in the U.S. or our AZ&Me™ Prescription Savings programs, please visit: www.astrazeneca-us.com or call 1-800-AZandMe (292-6363).
Photos/Multimedia Gallery Available: http://www.businesswire.com/cgi-bin/mmg.cgi?eid=6764628&lang=en